PHARMACY

Study finds hypertension best treated by doctor-pharmacist collaboration

BY Allison Cerra

NEW YORK Collaboration between doctors and pharmacists works best when treating patients with hypertension, a new study concluded.

A new study, published in the Nov. 23 issue of the Archives of Internal Medicine, assessed 402 people treated for high blood pressure at six clinics and divided into two groups. One group got the usual high blood pressure treatment, in which a prescription is written based on the doctor’s measurement of blood pressure, and a pharmacist simply fills the prescription. The other group was treated by doctor-pharmacist teams in which the pharmacists were trained to assess participants’ blood pressure and adjust both the kind of drugs prescribed and the dosage of those drugs.

After six months, blood pressure had dropped to the recommended level in 30% of the participants in the traditional treatment group, while 64% of those treated by a pharmacist-physician team achieved the goal.

“When physicians work with pharmacists, medications are intensified, dosages increased, medications used more effectively,” said Barry L. Carter, a professor in the University of Iowa College of Pharmacy and lead author of the report. “Medication compliance is lesser reason for the improvement.”

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

POLLS

Which area of the industry do you think Amazon’s entry would shake up the most?
PHARMACY

FDA approves Pharmaforce’s dorzolamide hydrochloride eye drops

BY Alaric DeArment

ROCKVILLE, Md. The Food and Drug Administration has approved a drug for treating high pressure in the eye, a condition that eventually can lead to blindness.

FDA records show that the agency approved Pharmaforce’s dorzolamide hydrochloride eye drops.

The drug is used to treat high pressure in the eye resulting from open-angle glaucoma and ocular hypertension and is a generic version of Merck & Co.’s Trusopt. 

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

POLLS

Which area of the industry do you think Amazon’s entry would shake up the most?
PHARMACY

FDA approves Amneal’s GERD generic

BY Alaric DeArment

ROCKVILLE, Md. The Food and Drug Administration has approved a generic version of a drug for treating gastroesophageal reflux disease in adolescents and adults.

According to FDA records, the agency approved Amneal Pharmaceuticals’ nizatidine oral solution in the 15-mg-per-15-mL strength.

The drug is used to treat symptoms of GERD in patients ages 12 years and older and is a generic version of Axid, made by Braintree Laboratories.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

POLLS

Which area of the industry do you think Amazon’s entry would shake up the most?